IonQ (IONQ) recently experienced a significant price move of approximately 51% over the last quarter, potentially influenced by key executive appointments and strategic alliances. The addition of Dr.

With its latest $50 billion U.S. manufacturing investment and record U.S. growth, is British AstraZeneca looking at itself as ...